Kukje Pharma Co., Ltd. (KRX:002720)
4,625.00
-5.00 (-0.11%)
At close: Sep 15, 2025
Kukje Pharma Market Cap
Kukje Pharma has a market cap or net worth of 93.36 billion as of September 16, 2025. Its market cap has decreased by -35.33% in one year.
Market Cap
93.36B
Enterprise Value
110.32B
Revenue
167.81B
Ranking
n/a
PE Ratio
14.65
Stock Price
4,625.00
Market Cap Chart
Since July 3, 2006, Kukje Pharma's market cap has increased from 29.64B to 93.36B, an increase of 214.98%. That is a compound annual growth rate of 6.15%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 16, 2025 | 93.36B | -9.39% |
Dec 30, 2024 | 103.03B | -14.06% |
Dec 28, 2023 | 119.89B | 12.98% |
Dec 29, 2022 | 106.12B | -5.98% |
Dec 30, 2021 | 112.86B | -36.19% |
Dec 30, 2020 | 176.87B | 118.14% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 74.02T |
Celltrion | 37.45T |
ALTEOGEN | 26.27T |
Yuhan | 8,902.50B |
SK Biopharmaceuticals | 8,724.10B |
Peptron | 7,094.04B |
PharmaResearch | 6,503.92B |
ABL Bio | 5,686.72B |